Last patient enrolled and safely dosed, completing patient recruitment for EOC Pharma’s phase I study in metastatic breast cancer (MBC) Data expected throughout 2020, with study completion in Q4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results